BioSpace News Archive

Business

Shionogi enters into a license and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics, Inc.

Shionogi & Co., Ltd. announced that it has entered into a license agreement with Hsiri Therapeutics, Inc.

June 6, 2018
·
4 min read
Business

Veterans’ Charity Teaches Warriors Bike Maintenance Skills

Wounded Warrior Project® (WWP) Soldier Ride® team members invited injured veterans to bring their bikes in for a special maintenance and fitting class with instructors from Pro Cycling of Colorado Springs. Warriors learned how to maintain their bikes before hitting the road, ensuring they get their cardio workouts done safely and smartly.

June 6, 2018
·
2 min read
Business

Solera Health Founder and CEO Brenda Schmidt Named “Best MedTech CEO”

2018 MedTech Breakthrough Awards Program Recognizes Solera Leader for Innovation and Vision

June 6, 2018
·
3 min read
Drug Development

Daiichi Sankyo to Present Late-Breaking Phase 3 Data for Single Agent Quizartinib in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations at Plenary Session at EHA 2018

Data from QuANTUM-R study demonstrating single agent quizartinib significantly prolongs overall survival compared to salvage chemotherapy in patients with relapsed/refractory acute myeloid leukemia (AML) with FLT3-ITD mutations to be unveiled

June 6, 2018
·
7 min read
Business

Gallagher Student Health partners with SilverCloud Health to bring behavioral health services to college campuses

Clinically-validated online platform helps students get faster, more focused care from their dorms as cases of depression, anxiety and stress reach epidemic levels

June 6, 2018
·
3 min read
Business

Senior Helpers® Bolsters Leadership with New CMO

Leading In-Home Senior Care Provider Prepares for Growth in 2018

June 6, 2018
·
2 min read
Drug Development

Peloton Therapeutics Initiates Phase 2 Trial of Oral HIF-2α Inhibitor PT2977 for Treatment of von Hippel-Lindau Disease-associated Kidney Cancer

PT2977 is a once-daily, oral inhibitor of HIF-2α, a transcription factor that has been implicated in the development and progression of renal cell carcinoma

June 6, 2018
·
4 min read
Pharm Country

Pfizer to Expand Venture Investing with $600 Million Commitment to Pfizer Ventures

Approximately 25% of new funding to be dedicated to neuroscience

June 6, 2018
·
6 min read
Business

Advaxis Appoints Molly Henderson as Chief Financial Officer

Effective June 6, 2018.

June 6, 2018
·
4 min read
Drug Development

BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist

Selective KOR Antagonist Represents BlackThorn’s Second Molecule to Enter Clinic

June 6, 2018
·
2 min read